Artiva Biotherapeutics reported total assets of $342.98M and total liabilities of $22.26M for the quarter ended Sep 2026, up 130.4% year over year. This balance sheet covers 14 quarters of results from Jun 2023 through Sep 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 | Sep2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash & EquivalentsCash & Equiv. | 53.70M | 65.89M | 53.50M | 48.20M | 34.25M | 55.88M | 40.24M | 30.40M | 28.47M | 25.51M | 26.70M | 20.96M | 301.45M | 61.23M |
| Short-term InvestmentsInvestments (Current) | 23.47M | 12.31M | 90.75M | 145.19M | 135.56M | 113.90M | 97.46M | 81.31M | 65.83M | 47.94M | 257.87M | |||
| Cash & Current Investments | 53.70M | 65.89M | 76.97M | 48.20M | 46.56M | 199.60M | 185.40M | 166.00M | 142.40M | 123.00M | 108.00M | 86.80M | 349.40M | 319.10M |
| Receivables - NetNet Receivables | 1.03M | 0.57M | 0.57M | |||||||||||
| Receivables - OtherOther Receivables | 0.72M | 0.89M | 0.13M | 0.15M | 0.23M | 0.03M | 0.08M | 0.07M | 0.14M | 0.02M | ||||
| Receivables | 1.76M | 1.46M | 0.70M | 0.15M | 0.23M | 0.03M | 0.08M | 0.07M | 0.14M | 0.02M | ||||
| Prepaid Assets | 1.09M | 1.73M | 3.23M | 3.06M | 3.81M | 6.67M | 6.48M | 4.59M | 1.96M | 2.74M | 7.13M | |||
| Current Assets | 79.82M | 49.75M | 150.57M | 188.63M | 170.00M | 149.07M | 129.52M | 112.67M | 88.74M | 352.28M | 326.25M | |||
| Non-Current Assets | ||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 8.10M | 7.32M | 6.86M | 6.37M | 7.06M | 6.89M | 6.98M | 6.62M | 6.22M | 5.67M | 6.17M | |||
| Long-Term Investments | 52.97M | |||||||||||||
| Other Non-Current Assets | 0.26M | 0.26M | 0.65M | 0.26M | 0.26M | 0.26M | 0.53M | 0.46M | 0.46M | 0.46M | 0.92M | 0.92M | 1.27M | 1.81M |
| Non-Current Assets | 25.29M | 26.16M | 75.03M | 20.95M | 21.26M | 20.33M | 19.34M | 18.27M | 17.22M | 16.36M | 16.73M | |||
| Assets | 105.11M | 75.91M | 225.60M | 209.58M | 191.26M | 169.39M | 148.86M | 130.94M | 105.96M | 368.63M | 342.98M | |||
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payables | 0.07M | 0.62M | 0.61M | 0.82M | 1.22M | 1.12M | 2.04M | 1.22M | 0.85M | 0.36M | 2.29M | 1.39M | 2.04M | |
| Payables | 0.07M | 0.62M | 0.61M | 0.82M | 1.22M | 1.12M | 2.04M | 1.22M | 0.85M | 0.36M | 2.29M | 1.39M | 2.04M | |
| Accumulated Expenses | 8.02M | 6.21M | 8.34M | 7.39M | 6.38M | 5.84M | 7.03M | 9.60M | 5.56M | 9.90M | 11.05M | |||
| Other Accumulated Expenses | 2.86M | 2.22M | 1.47M | 1.00M | 1.00M | 0.90M | 1.02M | 1.13M | 2.77M | 1.96M | ||||
| Current Leases | 3.60M | 0.12M | 0.12M | 0.12M | 0.13M | 0.11M | 0.08M | 0.04M | 0.01M | 3.30M | 3.32M | |||
| Current Taxes | 119.65M | 119.65M | ||||||||||||
| Total Current Liabilities | 12.23M | 10.83M | 13.29M | 12.25M | 12.20M | 10.77M | 11.12M | 13.09M | 10.88M | 14.58M | 16.41M | |||
| Non-Current Liabilities | ||||||||||||||
| Capital Leases | 0.11M | 0.08M | 0.04M | 0.01M | ||||||||||
| Minority Interest | 216.41M | 216.41M | ||||||||||||
| Operating Leases | 13.32M | 11.87M | 11.16M | 10.57M | 10.27M | 9.58M | 8.52M | 7.88M | 7.23M | 6.55M | 5.85M | |||
| Other Non-Current Liabilities | 25.17M | 27.79M | 0.07M | 0.07M | ||||||||||
| Total Non-Current Liabilities | 241.96M | 239.22M | 24.53M | 22.87M | ||||||||||
| Total Liabilities | 267.13M | 267.01M | 24.60M | 22.94M | 22.48M | 20.35M | 19.64M | 20.97M | 18.11M | 21.13M | 22.26M | |||
| Shareholder's Equity | ||||||||||||||
| Common Equity | -164.26M | -151.45M | -162.02M | -174.67M | -191.10M | 201.00M | 186.64M | 168.78M | 149.04M | 129.22M | 109.97M | 87.85M | 347.50M | 320.72M |
| Liabilities and Shareholders Equity | 105.11M | 75.91M | 225.60M | 209.58M | 191.26M | 169.39M | 148.86M | 130.94M | 105.96M | 368.63M | 342.98M | |||
| Retained Earnings | -181.31M | -213.12M | -230.60M | -246.68M | -267.00M | -288.25M | -309.80M | -330.55M | -354.10M | -379.10M | -407.90M |
Pull Artiva Biotherapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=ARTV&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "ARTV", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=ARTV&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();